When people start subjecting their pets to their toxic relationship patterns, you know it’s cause for concern. After dumping their…
Picture living in an ideal world where everyone wins—you, your clients, and your crops (albeit not your insects). This is…
Jag Sanger may have been unceremoniously removed from leading media house The Market Herald (ASX: TMH), but that has not…
Since the easing of regulatory red tape and wider societal acceptance of utilising cannabis for its medical properties, the medicinal…
During the lockdown, surely there were many things that you would think of doing once the lockdown is over. For…
How many tabs do you shuffle across every day? Probably more than you need to. Covid and hybrid work have…
As Covid fizzled out, the share price of medical device company Atomo Diagnostics (ASX: AT1) did, too, falling from $0.50…
Perhaps China decided to make its own version of the drug or perhaps it proved that it could do so…
Incannex Healthcare (ASX: IHL) has reported interim data from its Phase 2 clinical trials to treat anxiety through the use…
Aussies are some of the most enthusiastic adopters of new clinical drugs. In 2019, 95,000 of us participated in nearly…